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Background: Several biomarkers have been proposed for detecting Alzheimer’s disease
(AD) in its earliest stages, that is, in the predementia stage. In an attempt to find
noninvasive biomarkers, researchers have investigated the feasibility of neuroimaging
tools, such as MRI, SPECT as well as neurophysiological measurements using EEG.
Moreover, the increase of EEG alpha3/alpha2 frequency power ratio has been associated
with AD-converters subjects with mild cognitive impairment (MCI).
Objective: To study the association of alpha3/alpha2 frequency power ratio with regional
cerebral blood flow (rCBF) changes in subjects with MCI.
Methods: Twenty-seven adult subjects with MCI underwent EEG recording and perfusion
single-photon emission computed tomography (SPECT) evaluation. The alpha3/alpha2
frequency power ratio was computed for each subject. Two groups were obtained
according to the median values of alpha3/alpha2, at a cut-off of 1.17. Correlation between
brain perfusion and EEG markers were detected.
Results: Subjects with higher alpha3/alpha2 frequency power ratio showed a constant
trend to a lower perfusion than low alpha3/alpha2 group. The two groups were significantly
different as about the hippocampal volume and correlation with the theta frequency
activity.
Conclusion: There is a complex interplay between cerebral blood flow, theta frequency
activity, and hippocampal volume in MCI patients with prodromal Alzheimer’s disease,
characterized by higher EEG alpha3/alpha2 frequency power ratio.
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INTRODUCTION
The identification and validation of biomarkers for diagnosing,
monitoring progression, and predicting onset of Alzheimer’s dis-
esae (AD) has been a main focus of AD research in the past
10 years. In line with recently published research criteria., it is
becoming clear that the integration of different biomarkers is
a milestone for a correct and early diagnosis of mild cognitive
impairment (MCI) due to AD (Dubois et al., 2007; Albert et al.,
2011). To date, the most studied and validated biomarkers are
Abeta42 and Tau protein in the cerebrospinal fluid (CSF), glucose
metabolism on fluorodeoxyglucose positron emission tomogra-
phy (18F-FDG PET), regional cerebral blood flow (rCBF) on
single photon computed emission tomography (SPECT), atrophy
of hippocampal volume (HV) on magnetic resonance imaging
(MRI), and brain amyloid deposition on amyloid imaging with
PET (Hampel et al., 2008; Galluzzi et al., 2013). Anyway, some
controversies remain to debate. The latter biomarkers have a good
sensibility in identifying subjects with a neurodegenerative disor-
ders at high risk to convert in dementia, but they lack a reliable
specificity that allow a clear-cut diagnosis of the different subtypes
of dementias. Of note, in neurodegenerative disorders, like AD or
other dementias, the brain networks modifies many years before
clinical manifestations.
Recent SPECT studies have demonstrated that a large neu-
ral network is altered in subjects with prodromal AD, including
precuneus, medial temporal, parietal ad frontal cortices (Launes
et al., 1991; Rodriguez et al., 1999, 2004; Frisoni et al., 2003;
Gungor et al., 2005). For instance, selective rCBF reductions
in the left hippocampus and parahippocampal gyrus and in
extended areas of cerebral association cortex were demonstrated
in a 2 years follow-up clinical study with rCBF-SPECT (Kogure
et al., 2000; Pupi et al., 2005). Cross-sectional studies have
shown rCBF and regional metabolic rates of glusocse (rCM-
Rgl) reductions in the resting state throughout the cortex in AD,
involving distinctive brain structures such as the posterior cingu-
late/precuneus, temporoparietal, and frontal cortices (Minoshima
et al., 1994). A positive SPECT scan raised the likelihood of
diagnosing pathological AD from 84%, as defined by clinical
diagnosis, to 92% (Jagust et al., 2001; Frisoni, 2012). Recent
results show that there is a hippocampal rCBF hypoperfusion
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in patients with mild AD (Rodriguez et al., 2000), as well as
that baseline SPECT can support outcome prediction in sub-
jects with MCI (Nobili et al., 2009). Of note, rCBF (bilateral
parietal perfusion) and qEEG (especially the slowest frequen-
cies, i.e., 2–5.5Hz) are confirmed to be good descriptors of AD
severity. It is especially noteworthy that bilateral hippocampal
rCBF reduction was the perfusional index best correlated with
both cognitive performance and qEEG (Rodriguez et al., 1999,
2004).
In the conceptual frame of the integration of biomarkers for
an early and highly predictive diagnosis, the EEG could be a reli-
able tool (Moretti et al., 2003, 2004, 2007a,b, 2008a,b, 2009a,b,c,
2011, 2012, 2013a,b; Missonnier et al., 2010). Indeed, it is widely
accepted that the cerebral EEG rhythms reflect the underlying
brain network activity (Steriade et al., 1990; Steriade, 2006). As
a consequence, modifications in EEG rhythms could be an early
sign of disease associated with AD-related structural and func-
tional networks. Recently, it has been demonstrated that the
increase of high alpha relative to low alpha frequency power is
a reliable EEG marker of hippocampal atrophy (Moretti et al.,
2009a) and amigdalo-hippocampal complex atrophy (Moretti
et al., 2009b). Furthermore, the increase in alpha3/alpha2 power
ratio has been demonstrated predictive of conversion of patients
with MCI in AD, but not in non-AD dementia (Moretti et al.,
2011, 2013a,b). The same increase of alpha3/alpha2 frequency
power ratio was found to be correlated with hippocampal atro-
phy in subjects with AD (Moretti et al., 2012). Finally, a recent
study have shown that MCI subjects with highest alpha3/alpha2
frequency power ratio present a peculiar pattern of basal ganglia
and thalamic atrophy, detected with voxel-based-morphometry
(VBM) tecnique, as compared to MCI groups with middle and
low alpha3/alpha 2 power ratio (Moretti et al., 2012, 2013a,b).
The present explorative study shares the same theoretical back-
ground. It could be of remarkable scientific interest to confirm
that alpha3/alpha2 power ratio is a reliable diagnostic marker
extending his relationship with rCBF detected with SPECT. It is
not a simple association study between EEG and rCBF, because
the individuated cut-off for the alpha3/alpha2 frequency power
ratio makes it available to be used in the single patient and not
only at level group, as happens in most other studies. As a con-
sequence, the working hypothesis of the present study is that an
increase in alpha3/alpha2 EEG frequency power ratio would like
to be associated with lower brain perfusion in specific brain areas.
To the best of our knowledge, it is the first study that investi-
gates the association between a specific EEG marker, which has





MCI patients were taken from a prospective project on MCI
(“Mild Cognitive Impairment in Brescia—MCIBs”), aimed to
study the natural history of persons without dementia with appar-
ently primary cognitive deficits, i.e., not due to psychic or physical
conditions. The study protocol was approved by the local ethics
committee and all participants signed an informed participation
consent. Details on inclusion/exclusion criteria and on physical
and neurological examinations, performance-based tests of phys-
ical function, gait and balance and performed neuropsychological
battery have been previously published and are at disposable else-
where (Caroli et al., 2007a). Among the 56 MCI patients who
agreed to undergo MRI and SPECT scan, all consecutive 27 who
agreed also to undergo EEG recording were further considered.
Normal controls
We enrolled all 17 healthy subjects from a previous study on
cerebral perfusion correlates of conversion to AD with both an
MRI and a SPECT scan available (for inclusion/exclusion criteria
and for a detailed description of the enrolment procedure please
see Caroli et al., 2007a). Briefly, subjects were consecutive nor-
mal volunteers picked among those undergoing brain MRI scan
at the Neuroradiology Unit of the “Città di Brescia”Hospital in
Brescia from October 2004 to June 2006 for reasons unrelated
to cognition, or were healthy volunteers aged 65 years or older,
among MCI patients’ spouses, friends of them, and researchers’
acquaintances. All scans of enrolled subjects were normal on
visual assessment of a neuroradiologist. Subjects underwent mul-
tidimensional assessment including clinical, neurological, and
neuropsychological evaluations, and drawing of a blood sample
(not used for the purposes of the present study). Data coming
from normal controls were used only to computeW scores in each
selected perfusion ROI.
SPECT scan
Both patients and normal controls underwent SPECT scan in the
nuclear medicine department of the Ospedali Riuniti Hospital
in Bergamo. Each patient received an intravenous injection of
925MBq of technetium- 99m ethyl cysteinate dimer (99mTc-
ECD) in resting conditions, lying supine with eyes closed in a
quiet, dimly lit room. 40–60min after injection, brain SPECT was
performed using a dual-head rotating gamma camera (GE Elscint
Helix) equipped with low energy-high resolution, parallel hole
collimators. A 128 × 128 pixel matrix, zoom = 1.5, was used for
image acquisition with 120 views over a 360◦ orbit (in 3◦ steps)
with a pixel size and slice thickness of 2.94mm. Butterworth
filtered-back projection (order = 7, cutoff = 0.45 cycles/cm)
was used for image reconstruction, and attenuation correction
was performed using Chang’s method (attenuation coefficient =
0.11 cm-1). Images were exported in DICOM format.
SPECT processing protocol
To achieve a precise normalization, we generated a study-specific
SPECT template using both SPECT and MRI scans of all
patients and normal controls under study, following a proce-
dure described in detail elsewhere (Caroli et al., 2007a,b). Briefly,
we created a customized high-definition MRI template, we con-
verted SPECT scans to Analyze format using MRIcro (Rorden
and Brett, 2000), and we coregistered them to their respective
MRI scans with SPM2 (SPM, Statistical Parametric Mapping, ver-
sion 2 (2002). London: Functional Imaging Laboratory. Available
at: http://www.fil.ion.ucl.ac.uk/spm/software/spm2). We nor-
malized each MRI to the customized MRI template through
a nonlinear transformation (cutoff 25mm), and we applied
Frontiers in Behavioral Neuroscience www.frontiersin.org December 2013 | Volume 7 | Article 188 | 2
Moretti et al. EEG, SPECT, MCI
the normalization parameters to the coregistered SPECT. We
obtained the customized SPECT template as the mean of all
the latter normalized SPECT images. The creation of a study-
specific template allows for better normalization, since low uptake
in ventricular structures and cortical hypoperfusion effects are
frequently present in elderly patients. For each coregistered
SPECT scan, we set the origin to the anterior commissure, using
the respective MRI image as a reference, and we processed all
scans with SPM2 according to an optimized processing proto-
col described in detail elsewhere (Caroli et al., 2007a,b). Brain
perfusion correlates of medial temporal lobe atrophy and white
matter hyperintensities in MCI were obtained as follows: (I) we
smoothed each scan with a 10mm full width at half maximum
(FWHM) Gaussian, and spatially normalized it with an affine
deformation to the customized SPECT template; we applied the
same deformation to the unsmoothed images; (II) we masked
the unsmoothed normalized images from I to remove scalp
activity using SPM2’s “brainmask.” We smoothed with a 10mm
FWHM Gaussian, and warped them to the customized template
with a nonlinear transformation (cutoff 25mm); we applied the
same transformation to the unsmoothed masked images; (III)
we smoothed the normalized unsmoothed images from II with a
12mm FWHMGaussian. The following Region of Interest (ROI)
were chosen for perfusion analyses in each hemisphere from
the Pick atlas by a sub-routine implemented on SPM2: frontal,
parietal and temporal lobes, the thalamus and the hippocampal-
amygdalar complex (Maldjian et al., 2003). The choice of these
regions was based on previous SPECT and PET studies in sub-
jects withMCI (Staffen et al., 2009; Alegret et al., 2012; Yoon et al.,
2012).
The whole cerebellum was chosen for normalization of ROI
counts. Since perfusion values in selected ROIs did not account
for age, pertinent age corrected perfusion values (hereafter called
W scores), were computed in each selected ROI, following a
previously published procedure (Jack et al., 1997).
MR imaging
Both patients and normal controls underwent brain T1-
weighted MRI in the neuroradiology department of the Città
di Brescia Hospital, as previously discussed (Caroli et al.,
2007b). MR images were processed with SPM2 following an
optimized Voxel- Based Morphometry protocol, described in
detail elsewhere (Frisoni et al., 2005). Manual tracings of
hippocampal and total intracranial volumes were performed
using DISPLAY (DISPLAY, Brain Imaging Center—Montreal
Neurological Institute. Available at: http://www.bic.mni.mcgill.
ca/software). Native hippocampal volumes were normalized to
the individual intracranial volumes and rescaled to the mean total
intracranial volume according to the following formula ([vol-
ume/individual total intracranial volume]*mean total intracra-
nial volume). Total white matter lesions load was assessed trough
visual Wahlund scale on T2 and FLAIR MRI images (Wahlund
et al., 2001).
EEG recordings
The EEG activity was recorded continuously from 19 sites by
using electrodes set in an elastic cap (Electro-Cap International,
Inc.) and positioned according to the 10–20 international systems
(Fp1, Fp2, F7, F3, Fz, F4, F8, T3, C3, Cz, C4, T4, T5, P3, Pz, P4, T6,
O1, and O2). All recordings were obtained in the morning with
subjects resting comfortably. In order to keep constant the level of
vigilance, an operator controlled on-line the subject and the EEG
traces, alerting the subject any time there were signs of behavioral
and/or EEG drowsiness. The ground electrode was placed in front
of Fz. The left and right mastoids served as reference for all elec-
trodes. The recordings were used off-line to re-reference the scalp
recordings to the common average. Re-referencing was done prior
to the EEG artifact detection and analysis. Data were recorded
with a band-pass filter of 0.3–70Hz, and digitized at a sampling
rate of 250Hz (BrainAmp, BrainProducts, Germany). Electrodes-
skin impedance was set below 5 khz. Horizontal and vertical
eye movements were detected by recording the electrooculogram
(EOG). The recording lasted 5min, with subjects with closed eyes.
Longer recordings would have reduced the variability of the data,
but they would also have increased the possibility of slowing of
EEG oscillations due to reduced vigilance and arousal. EEG data
were then analyzed and fragmented off-line in consecutive epochs
of 2 s, with a frequency resolution of 0.5Hz. The average num-
ber of epochs analyzed was 140, ranging from 130–150. The EEG
epochs with ocular, muscular and other types of artifact were
preliminary identified by a computerized automatic procedure
(Moretti et al., 2003). Two expert electroencephalographists man-
ually double-checked and confirmed the automatic selections.
The epochs with ocular, muscular, and other types of artifacts
were discarded.
Analysis of individual frequency bands
A digital FFT-based power spectrum analysis (Welch technique,
Hanning windowing function, no phase shift) computed—
ranging from 2–45Hz—the power density of EEG rhythms with
a 0.5Hz frequency resolution. Two anchor frequencies were
selected according to the literature guidelines (Klimesch, 1997,
1999), that is, the theta/alpha transition frequency (TF) and the
individual alpha frequency (IAF) peak. These anchor frequen-
cies were computed on the power spectra averaged across all
recording electrodes. The TF marks the TF between the theta
and alpha bands, and represents an estimate of the frequency at
which the theta and alpha spectra intersect. TF was computed
as the minimum power in the alpha frequency range, since our
EEG recordings were performed at rest. The IAF represents the
frequency with the maximum power peak within the extended
alpha range (5–14Hz). Based on TF and IAF, we estimated the
frequency band range for each subject, as follows: delta from
TF-4 to TF- 2, theta from TF-2 to TF, low alpha band (alpha1
and alpha2) from TF to IAF, and high alpha band (or alpha3)
from IAF to IAF + 2. The alpha1 and alpha2 bands were com-
puted for each subject as follows: alpha1 from TF to the middle
point of the TF-IAF range, and alpha2 from such middle point
to the IAF peak (Moretti et al., 2004, 2007a,b, 2008a,b, 2009a,b).
Moreover, within theta frequency the frequency peak (individ-
ual theta frequency, ITF) was also individuated. The mean fre-
quency range computed in MCI subjects considered as a whole
are: delta 2.9–4.9Hz; theta 4.9–6.9Hz; alpha1 6.9–8.9Hz; alpha2
8.9–10.9Hz; alpha3 10.9–12.9Hz;. Finally, in the frequency bands
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determined on an individual basis, we computed the relative
power spectra for each subject. The relative power density for each
frequency band was computed as the ratio between the absolute
power and the mean power spectra from 2–45Hz. The relative
band power at each band was defined as the mean of the rela-
tive band power for each frequency bin within that band. The
alpha3/alpha2 frequency power ratio was computed in all sub-
jects. The 27 MCI patients enrolled for the present study with
available MRI, SPECT, and EEG recording were finally classi-
fied as at high risk (when the alpha3/alpha 2 EEG frequency
power ratio median was above 1.17) or at low risk (when the
alpha3/alpha 2 EEG frequency power ratio median was under
1.17) to develop AD. The choice of this cut-off was based on
the median value, in order to balance the sample size of the two
groups. Moreover, it was overlapping with the value we detected
in previous studies, showing an high risk to develop AD in MCI
subjects with the alpha3/alpha 2 EEG frequency power ratio above
the value of 1.17 (Moretti et al., 2011). Of note, this cut-off indi-
viduates a MCI group with different pattern of both hippocampal
atrophy, amigdalo-hippocampal complex atrophy, and basal gan-
glia and thalamus gray matter lesions as compared to MCI group
with alpha3/alpha2 EEG frequency power ratio values below 1.17
(Moretti et al., 2009b, 2011, 2012).
STATISTICAL ANALYSIS
All statistical analyses were performed using SPSS software ver.
13.0. We investigated significance of the difference between the
two groups (MCI at low and at high risk to develop AD) in socio-
demographic, clinical and cognitive features using χ2 test for
categorical variables (sex, and ApoE carriers) and Student’s inde-
pendent t-test for continuous variables (volumetric, perfusion
features, and EEG frequencies). In all cases we set the significant
threshold at p < 0.05. Since native SPECT scans were coregistered
to their respective MRI images, and the study-specific SPECT
template was coregistered to the high-definition MRI template,
all the normalized SPECT and MRI images used for the statis-
tical analysis were coregistered to the SPM standard anatomical
space. Moreover, Pearson’s r correlations were assessed between
the selected perfusion ROIs (in terms of age corrected W scores)
and the acquired EEG frequencies in both groups.
RESULTS
Twenty-seven MCI patients were enrolled for the present study
and they were classified as at high risk (when the a3/a2 EEG
rhythm median was above 1.17) or at low risk (when the a3/a2
EEG rhythm median was under 1.17) to develop AD. The two
groups (AD high risk, N = 13, AD low risk, N = 14) were sim-
ilar for age (p = 0.56), education in years (p = 0.87), gender
(p = 0.17), ApoE genotype (p = 0.15), MMSE scores (p = 0.31),
and white matter lesions load (p = 0.88; Table 1). Figure 1 shows
the visual rating scale of the SPECT scans representative of nor-
mal control, MCI with low and MCI with high risk to convert
in AD, respectively. ANOVA results show that the selected cut-
off was effective in detecting two different groups: patients with
high risk to develop AD show significantly higher alpha3/alpha2
power ratio than patients with low risk (p = 0.0001). Moreover, a
control analysis was performed on the the single frequencies. The
results show that the increase of alpha3/alpha2 frequency power
ratio was due to both increase of alpha3 (p = 0.001) and decrease
of alpha2 (p = 0.0001) and not to the modification of a single fre-
quency. This control analysis was performed because the change
of only one frequency could be due to the chance. But it was not
the case.
Of note, no differences were found for beta 1, beta 2, gamma,
theta EEG power, and theta/gamma frequency power ratio (all
p > 0.11) (Table 2). Although the mean perfusion in all the
selected ROIs was similar between groups (all p > 0.38), in the
group with high alpha3/alpha2 frequency ratio there is a constant
trend to a lower perfusion (see Figure 2). Moreover, left hip-
pocampal volumes were lower for AD-high risk patients respect
to low risk ones (p = 0.001) (Table 1). Data coming from nor-
mal controls were used only to compute W scores in each selected
perfusion ROI, but their summarized socio-demographic, clini-
cal, and volumetric features as well as their perfusion W scores
can be found in Table 3.
In patients at low risk to develop AD, significant Pearson’s
R negative correlation was found between perfusion in the hip-
pocampal complex ROI and theta rhythm (r = −0.544, p =
0.044; Figure 3).
In patients at high risk to develop AD otherwise, more and dis-
similar correlations were found: a positive correlation, inverted
respect to patients at low risk, between the perfusion in the
hippocampal complex ROI and theta rhythm (r = 0.729, p =
0.005; Figure 4), while temporal ROI correlated positively with
theta/gamma ratio rhythms (r = 0.736, p = 0.004; Figure 5). No
other significant correlations were found in both groups between
perfusion ROIs and other EEG rhythms or hippocampal volumes.
Moreover, no significant correlations were found between hip-
pocampal complex ROI and theta rhythm pooling low and high
risk patients together (r = 0.086, p = 0.671).
DISCUSSION
The EEG alpha3/alpha2 frequency ratio in previous studies has
proved useful in identifying a group at greater risk of convert-
ing in AD (Moretti et al., 2011). This group has the higher
alpha3/alpha2 EEG frequency power ratio, at an orientative cut-
off of about 1.17. The choice of a cut off allows the individuation
of a particular population inside the group of patients with MCI.
It is a very important issue of the study and makes it differ-
ent from other works, usually distinguishing the MCI subjects
on clinical, structural or functional aspects but not on a neuro-
physiological marker. The particular group individuated by the
higher alpha3/alpha2 power ratio is at major risk to develope AD.
The possibility to detect this risk not only in a group but also
in the single patient through a cut-off is also an original con-
tribution of this study. To be validated this EEG marker needs
correlation study withmorphostructural or functional milestones
peculiar of AD, like as rCBF. These present results confirm that
the relationship alpha3/alpha 2 identifies two distinct groups: the
higher ratio characterizes a group with a smaller hippocampal
volume and a constant trend of lower cerebral perfusion, even
if it does not reach significance. These results confirm previous
studies which have shown that patients with high risk of devel-
oping AD have left hippocampal atrophy and reduced SPECT
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Table 1 | Socio-demographic, clinical, and volumetric features in MCI patients by risk to develop AD.
At low-risk MCI At high-risk MCI p
N 14 13
Age (years) [Range] 69.1 ± 7.6 [57 ÷ 83] 70.6 ± 5.5 [62 ÷ 78] 0.555
Gender (females) 6 (43%) 9 (69%) 0.168
Education (years) [Range] 8.2 ± 4.3 [4 ÷ 18] 7.9 ± 4.5 [3 ÷ 18] 0.865
MMSE score [Range] 27.9 ± 1.6 [25 ÷ 30] 27.2 ± 1.9 [24 ÷ 29] 0.309
ApoE ε4 genotype (carriers) 2 (29%) 5 (39%) 0.152
Left hippocampal volume (mm3) [Range] 2606 ± 353 [1923 ÷ 3017] 2073 ± 412 [1234 ÷ 2641] 0.001
Right hippocampal volume (mm3) [Range] 2581 ± 473 [1549 ÷ 3150] 2296 ± 501 [1589 ÷ 3086] 141
Wahlund total score [Range] 3.58 ± 3.29 [0.0 ÷ 10.0] 3.78 ± 2.63 [0.0 ÷ 7.0] 0.886
Values are mean ± SD for continuous variables or frequency (percentage) for gender and ApoE carriers.
FIGURE 1 | SPECT visual rating. The output shows a SPECT
visual inspection of glucose uptake metabolism: the white square
denotes an area of mild-to-moderate (purple to blue) temporparietal
hypometabolism in one of the 14 at low risk and in one of the
13 at high risk MCI patient respect to one of the 17 enrolled
controls.
Table 2 | Brain perfusion and EEG rhythms in MCI patients by risk to develop AD
At low-risk MCI At high-risk MCI p
N 14 13
Frontal perfusion (W scores) [Range] 1.2 ± 2.7 [−3.5 ÷ 5.5] 0.7 ± 3.6 [−3.1 ÷ 11.8] 0.707
Parietal perfusion (W scores) [Range] 2.2 ± 2.7 [−2.5 ÷ 7.0] 1.7 ± 3.8 [−2.3 ÷ 13.3] 0.698
Temporal perfusion (W scores) [Range] −4.9 ± 2.5 [−8.9 ÷ 0.6] −5.6 ± 1.5 [−7.8 ÷ −3.4] 0.384
Hippocampal complex perfusion (W scores) [Range] −2.3 ± 2.0 [−6.5 ÷ 0.1] −2.8 ± 3.1 [−9.2 ÷ 0.6] 0.616
Thalamic perfusion (W scores) [Range] −0.5 ± 1.9 [−3.6 ÷ 4.9] −0.6 ± 1.4 [−3.4 ÷ 2.4] 0.860
EEG alpha 1 [Range] 1.3 ± 0.1 [1.1 ÷ 1.6] 1.4 ± 0.1 [1.3 ÷ 1.5] 0.117
EEG alpha 2 [Range] 3.6 ± 0.3 [3.2 ÷ 4.1] 3.1 ± 0.2 [2.7 ÷ 3.5] 0.0001
EEG alpha 3 [Range] 3.7 ± 0.2 [3.2 ÷ 4.0] 4.0 ± 0.2 [3.7 ÷ 4.4] 0.001
EEG alpha 3/alpha 2 [Range] 1.0 ± 0.1 [0.9 ÷ 1.1] 1.3 ± 0.1 [1.2 ÷ 1.5] 0.0001
EEG beta 1 [Range] 0.5 ± 0.2 [0.3 ÷ 1.0] 0.4 ± 0.1 [0.2 ÷ 0.5] 0.175
EEG beta 2 [Range] 0.4 ± 0.1 [0.3 ÷ 0.7] 0.4 ± 0.1 [0.2 ÷ 0.5] 0.393
EEG theta [Range] 1.3 ± 0.1 [1.2 ÷ 1.5] 1.3 ± 0.1 [1.1 ÷ 1.6] 0.554
EEG gamma [Range] 1.0 ± 0.2 [0.6 ÷ 1.5] 0.8 ± 0.2 [0.6 ÷ 1.2] 0.114
EEG theta/gamma [Range] 1.4 ± 0.3 [0.8 ÷ 2.1] 1.6 ± 0.5 [1.9 ÷ 2.9] 0.120
Values are mean ± SD. Brain perfusion is always expressed as age-corrected scores (W scores).
perfusion (Frisoni et al., 2003, 2005; Frisoni, 2012). Actually, amy-
loid plaques deposition, NFT formation, neuronal loss, decrease
in dendritic extent, and synaptic depletion are thought to dis-
turb the communication among various cortical areas, resulting
in anatomic isolation and decreased perfusion of many cortical
zones (Golde, 2003). The lack of a significant difference is an
obvious limitation of the work. One possible explanation is the
relatively small sample size of the two groups. Given that the
trend is constant, a larger sample in both groups could exploit
a significant statistical difference. On the other side, it is possi-
ble that when considering two groups of patients, both with a
MCI, the rCBF is not so sensible to show a large difference, as
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FIGURE 2 | Histograms of the perfusion W scores distribution
in at low and at high risk patients for hippocampal
complex (left column) and temporal (right column) ROIs.
Generally, for at high risk MCIs, perfusion scores are attested
on lower values than at low risk patients. Black curve is the
approximation to the normal distribution. X axis represents
perfusion W scores while Y axis depicts the number of patients
(frequency) for each W score.
it could verify in the case of the glucose metabolism evaluation.
Previous studies have demonstrated that metabolic, but not per-
fusional, patterns were related to severity of cognitive impairment
and were more sensible in detecting prodromal MCI due to AD
(Mielke et al., 1994; Forlenza et al., 2010). Further studies, with
larger sample size, are mandatory to confirm these results. The
present study shows a correlation between cerebral perfusion and
theta rhythm. Anyway, the correlation emerges only when con-
sidering the different groups individuated on the alpha3/alpha2
frequency power ratio. This is confirmed by the finding that when
the groups are merged, no correlation could be found. This is the
main aspect of the study and the peculiar novelty of the results.
The patients at lower risk to develop AD, who have a constant
trend toward a higher brain regional blood perfusion, maintains
low levels of hippocampal theta power while in patients at higher
risk, with a basically lower cerebral blood perfusion, theta rhythm
tends to be higher. This latter finding is also confirmed by the
increased ratio of theta/ gamma frequency power ratio in the
temporal region, adjacent to the hippocampus. A lot of previ-
ous studies have shown an increase of theta rhythm in patients
with mild AD (Rodriguez et al., 2004, 2011), so that the increase
of theta power is a robust features of AD. Theta rhythms are
usually not appreciated in normal awakening EEG. However, a
theta power increase is observed over the frontal and temporal
areas during learning and memory tasks. The theta rhythms that
are recorded during these tasks are thought to be produced by
the activation of septal-hippocampal system. Hippocampus has
a cholinergic innervation originating from basal forebrain, the
medial septum, and the vertical limb of the diagonal band of
Broca. Populations of GABAergic and glutamatergic neurons have
also been described in several basal forebrain structures. The syn-
chronized depolarization of hippocampal neurons produces field
potentials that have a main frequency of 3–12Hz and are usu-
ally known as hippocampal theta rhythm (Bland and Colom,
1993). A cholinergic-glutamatergic hypothesis of AD, in which
most symptoms may be explained by cholinergic-glutamatergic
deficits, has been advanced. Neuronal injury/loss may include
an excitotoxic component that possibly contributes to the early
cholinergic deficit. This excitotoxic componentmay occur, at least
in part, at the septal level where somas of cholinergic neurons are
found. This insult may modify septal networks and contribute
to the abnormal information processing observed in AD brain,
including its hyperexcitability states. According to this theory,
the increased theta production in AD would derive from hyper-
excitability of the septal-hippocampal system (Colom, 2006).
Of note, such pattern of decreased cerebral blood flow activity
and increased excitability was found even prior to the onset of
cognitive impairment and cortical atrophy (Pupi et al., 2005).
On the other hand, it should be taken in mind that EEG
measures electrical field variations, and a number of clinical
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Table 3 | Socio-demographic, clinical volumetric, and brain perfusion
features of normal elders enrolled in the study.
Normal controls
N 17
Age (years) [Range] 69.6 ± 3.2 [65 ÷ 74]
Gender (females) 9 (53%)
Education (years) [Range] 9.8 ± 4.1 [5 ÷ 19]
MMSE score [Range] 27.8 ± 1.6 [24 ÷ 30]
ApoE ε4 genotype (carriers)* 1/12 (8%)
Left hippocampal volume (mm3)
[Range]
2770 ± 274 [2089 ÷ 3351]
Right hippocampal volume (mm3)
[Range]
2715 ± 221 [1881 ÷ 3139]
Frontal perfusion (W scores) [Range] 1.2 ± 0.1 [1.1 ÷ 1.3]
Parietal perfusion (W scores) [Range] 1.4 ± 0.1 [1.3 ÷ 1.5]
Temporal perfusion (W scores)
[Range]
0.4 ± 0.01 [0.4 ÷ 0.5]
Hippocampal complex perfusion
(W scores) [Range]
0.2 ± 0.01 [0.18 ÷ 0.21]
Thalamic perfusion (W scores)
[Range]
0.5 ± 0.02 [0.49 ÷ 0.57]
Values are mean ± SD for continuous variables or frequency (percentage) for
gender and ApoE carriers. Brain perfusion is always expressed as age-corrected
scores (W scores).
*Missing data for 5 normal controls.
FIGURE 3 | Pearson r correlations between EEG theta rhythm and
hippocampal complex perfusion in patients at low risk to develop AD.
conditions can disturb the normal electrical field of the brain.
For instance, electrolyte changes may alter the appearance and
time variation of the brain-generated electrical fields, and med-
ications can slow the posterior dominant rhythm. Moreover,
in assessing the frequency of the theta rhythm, cerebrovascular
lesions should be considered as a possible cause of increase. By
means of observations in patients with ischemic lesions, it has
been suggested that delays in corticocortical fiber propagation
FIGURE 4 | Pearson r correlations between EEG theta rhythm and
hippocampal complex perfusion in patients at high risk to develop AD.
FIGURE 5 | Pearson r correlations between EEG theta/gamma
frequency ratio and temporal ROI perfusion in patients at high risk to
develop AD.
may play a global role in determining human EEG frequen-
cies, increasing the amount of theta activity (Thatcher et al.,
1998). Increased T2 relaxation times in cortical gray matter
and white matter were correlated with a shift in relative EEG
power to lower frequencies in the theta range (4–7Hz) and
reduced cognitive performance (Rodriguez et al., 2011). Anyway,
none of our patients suffered from acute ischemic lesions and
there was no difference in the cerebrovascular load between the
two groups. Moreover, the EEG frequency details of patients
with chronic cerebrovascular load has been recently investigated
(Moretti et al., 2007a) and they are not compatible with an high
alpha3/alpha 2 frequency ratio increase. So, we are confident the
our results are of neurodegenerative origin. On the whole, it
emerges a picture in which it is not the simple cerebral blood
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perfusion rate nor a single brain rhythm that reflect the com-
plexity of functional alteration in AD. A previous work already
found that none of the regions of interest of the SPECT scans
were significantly correlated with clinical severity (Müller et al.,
1997).
CONCLUSION
Our study reveals original and unknown aspects of a quite com-
plex interplay between cerebral blood flow and electric activity
dynamics and its association with hippocampal volume in a
peculiar group of MCI patients, characterized by higher EEG
alpha3/alpha2 frequency ratio.
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